• LAST PRICE
    0.1174
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    0.0905 / 0.1174
  • Day Range
    Low 0.0803
    High 0.1197
  • 52 Week Range
    Low 0.0650
    High 3.1950
  • Volume
    1,562,369
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 0.0845
TimeVolumeGRTX
09:32 ET242000.099
09:43 ET2170.085
09:45 ET72150.0803
09:50 ET72150.091
10:06 ET240000.099
10:08 ET1142000.1022
10:10 ET400000.1022
10:12 ET58740.1
10:15 ET238570.101
10:21 ET60000.10655
10:30 ET20000.1053
10:33 ET1475850.097
10:35 ET289340.1022
10:37 ET100000.1095
10:48 ET98030.11
10:55 ET309900.112
10:57 ET1994670.11
11:00 ET130000.11
11:04 ET90000.11
11:08 ET203500.111
11:09 ET104990.1025
11:13 ET160000.1105
11:18 ET24090.107375
11:22 ET170000.11
11:24 ET182700.1031
11:26 ET5000.10855
11:33 ET100000.10855
11:36 ET1700.1099
11:45 ET100000.114
11:54 ET150000.1099
11:56 ET51000.1099
12:02 ET6000.10514
12:07 ET166280.10845
12:12 ET25000.10845
12:14 ET150000.103
12:18 ET40000.1119
12:21 ET118850.1035
12:50 ET1930.11
12:52 ET1180.11
12:57 ET21000.11
12:59 ET64000.113
01:01 ET440710.112
01:14 ET75000.1145
01:15 ET4620.1121
01:21 ET230000.1145
01:24 ET170000.1146
01:28 ET380110.118
01:30 ET1445380.115
01:35 ET156740.115
01:39 ET15000.1125
01:42 ET250000.1126
01:44 ET25000.1126
01:48 ET70000.1195
01:50 ET30000.113
01:51 ET1010.113
02:02 ET100000.115
02:11 ET7320.119
02:18 ET630000.1197
02:20 ET150000.1152
02:42 ET100000.1155
02:44 ET240000.11794
02:49 ET50000.1186
02:51 ET150000.119
03:03 ET300000.1188
03:09 ET25000.1186
03:18 ET100000.1176
03:23 ET400000.1167
03:27 ET11690.1166
03:36 ET40000.1167
03:43 ET255220.1167
03:45 ET100000.11584
03:48 ET1500.1168
03:54 ET500000.118
03:56 ET210000.1168
03:57 ET67000.118
03:59 ET5000.11735
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesGRTX
Galera Therapeutics Inc
4.6M
-0.1x
---
United StatesADIL
Adial Pharmaceuticals Inc
4.7M
-0.2x
---
United StatesPTIX
Protagenic Therapeutics Inc
4.4M
-0.7x
---
United StatesMYMD
Mymd Pharmaceuticals Inc
4.5M
-0.3x
---
United StatesENTO
Entero Therapeutics Inc
4.5M
0.0x
---
United StatesENVB
Enveric Biosciences Inc
4.7M
-0.1x
---
As of 2024-06-25

Company Information

Galera Therapeutics, Inc. is a biopharmaceutical company focused on developing a pipeline of novel, therapeutic candidates that have the potential to transform radiotherapy in cancer. The Company’s lead product candidate, avasopasem manganese (avasopasem), is a highly selective small molecule dismutase mimetic that the Company is developing for the reduction of severe oral mucositis (SOM) in patients with head and neck cancer (HNC), the reduction of esophagitis in patients with lung cancer, and the reduction of cisplatin-induced kidney damage in patients with cancer. The Company’s second product candidate, rucosopasem manganese (rucosopasem), is in development to augment the anti-cancer efficacy of stereotactic body radiation therapy in patients with non-small cell lung cancer and locally advanced pancreatic cancer. Rucosopasem is an orphan drug designation and orphan medicinal product designation for the treatment of pancreatic cancer.

Contact Information

Headquarters
45 Liberty Blvd., Suite 230MALVERN, PA, United States 19355
Phone
610-725-1500
Fax
302-636-5454

Executives

Independent Chairman of the Board
Michael Powell
President, Chief Executive Officer, Director
J. Mel Sorensen
Chief Financial Officer, Secretary
Christopher Degnan
Chief Legal & Compliance Officer and Secretary
Jennifer Stacey
Chief Medical Officer
Eugene Kennedy

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$4.6M
Revenue (TTM)
$0.00
Shares Outstanding
54.4M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.93
EPS
$-1.00
Book Value
$-2.41
P/E Ratio
-0.1x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.